30-01-2023, 20:01

Aprea Therapeutics Appoints John Hamill as Chief Financial

DOYLESTOWN, Pa., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical
Globe Newswire30-01-2023, 20:01